Michael Guger

14PUBLICATIONS
38CO-AUTHORS
Regenerative medicine (incl. stem cells)Motor controlNanomedicineEpidemiological methodsSensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 12, 2026
The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.

|Dec 06, 2025
Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?

Gabriel Bsteh, Stefanie Marti, Helly Hammer

|Jul 05, 2025
De-Escalation Treatment Strategies From Natalizumab in Patients With Relapsing Multiple Sclerosis in Austria.

Michael Guger, Christian Enzinger, Bettina Heschl

|Mar 02, 2024
Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.

Michael Guger, Christian Enzinger, Fritz Leutmezer

|Mar 19, 2023
Non-interventional, prospective, observational study on spasticity-associated symptom control with nabiximols as add-on therapy in patients with multiple sclerosis spasticity in Austria.

Michael Guger, Robert Hatschenberger, Fritz Leutmezer

|Mar 02, 2023
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria.

Michael Guger, Christian Enzinger, Fritz Leutmezer

Pageof 3

Frequent Collaborators

4 joint publications

Gabriel Bsteh

3 joint publications

Franziska Di Pauli

3 joint publications

Thomas Berger

2 joint publications

Jörg Kraus